Neil Kumar, CEO, Director, Ten Percent Owner at Eidos Therapeutics, holds 6.88M shares in BridgeBio Pharma (Ticker: BBIO), holds 24.58M shares in Eidos Therapeutics (Ticker: EIDX).

See the Hottest Stocks Based on Insider Trading >

Neil Kumar
Eidos Therapeutics (EIDX)
CEO, Director, Ten Percent Owner

Ranked #32,526 out of 98,624 Corporate Insiders

Profitable Transactions

3 out of 4 Profitable Transactions

Average Return

+6.80%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

BBIO

A breakdown of Neil Kumar's holdings

See the Top Stocks by Insiders

Insider Roles

BridgeBio Pharma
(BBIO)

CEO & President, Director

Roles that Neil Kumar holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Eidos Therapeutics
(EIDX)

Rating:Informative Buy

Date:May 29, 2019 - May 29, 2020

Return:+57.20%

The most profitable trade made by Neil Kumar

See the Latest Stocks Traded by Insiders

Neil Kumar's Trading History

EIDX

Eidos Therapeutics

Jul 08, 2019

―

Informative Buy

26.38M

$3.00B

BBIO

BridgeBio Pharma

Feb 21, 2024

CEO & President, Director

Uninformative Buy

1.78M

$185.86M

List of latest transactions for each holding click on a transaction to see Neil Kumar's performance on stock

See All Insider Trading from Today

Neil Kumar insider profile FAQ

What is the percentage of profitable transactions made by Neil Kumar?

The percentage of profitable transactions made by Neil Kumar is 75%.

What is the average return per transaction made by Neil Kumar?

The average return per transaction made by Neil Kumar is 6.80%.

What stocks does Neil Kumar hold?

Neil Kumar holds: EIDX, BBIO stocks.

What was Neil Kumar’s latest transaction?

Neil Kumar latest transaction was an Uninformative Buy of $1.78M.

What was Neil Kumar's most profitable transaction?

Neil Kumar’s most profitable transaction was an Informative Buy of EIDX stock on May 29, 2019. The return on the trade was 57.20%.

What is Neil Kumar's role in Eidos Therapeutics?

Neil Kumar's role in Eidos Therapeutics is CEO, Director, Ten Percent Owner.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Neil Kumar Insider Profile

Neil Kumar Eidos Therapeutics (EIDX)CEO, Director, Ten Percent Owner